Page last updated: 2024-12-10

quercetin 3-o-methyl ether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

quercetin 3-O-methyl ether: from Rhamnus species; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3',4',5,7-tetrahydroxy-3-methoxyflavone : A tetrahydroxyflavone having the 4-hydroxy groups located at the 3'- 4'- 5- and 7-positions as well as a methoxy group at the 2-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
RhamnusgenusA plant genus of the family RHAMNACEAE. This genus is often called buckthorn but should not be confused with HIPPOPHAE or KARWINSKIA. Some RHAMNUS species have been reclassified into this genus. F. purshiana bark is cascara sagrada. Members contain frangulanin, frangulin, and anthraquinones such as EMODIN.[MeSH]RhamnaceaeThe buckthorn plant family, of the order Rhamnales, includes some species with edible fruits and some that are medicinal.[MeSH]

Cross-References

ID SourceID
PubMed CID5280681
CHEMBL ID163316
CHEBI ID16860
SCHEMBL ID380558
MeSH IDM0430168

Synonyms (64)

Synonym
CHEBI:16860 ,
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-methoxy-4h-1-benzopyran-4-one
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-methoxy-4h-chromen-4-one
3',4',5',7'-tetrahydroxy-3-methoxyflavone
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-methoxy-1-benzopyran-4-one)
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-methoxy-chromen-4-one
3-o-mq
quercetin-3-o-methyl ether
tnp00037
NCGC00017391-01
ACON1_000818
OPREA1_264124
C04443
3',4',5,7-tetrahydroxy-3-methoxyflavone
3-methoxy-5,7,3',4'-tetrahydroxyflavone
3-o-methylquercetin
4h-1-benzopyran-4-one,4-dihydroxyphenyl)-5,7-dihydroxy-3-methoxy-
flavone,4',5,7-tetrahydroxy-3-methoxy-
nsc154016
1486-70-0
nsc-154016
MLS000877018
smr000440662
NCGC00142365-01
MEGXP0_000771
3-methoxyluteolin
bdbm50240896
3'',4'',5,7-tetrahydroxy-3-methoxyflavone
cid_5280681
CHEMBL163316 ,
LMPK12112729
quercetin 3-methyl ether
NCGC00017391-03
NCGC00017391-02
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-methoxychromen-4-one
4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-methoxy-
nsc 154016
quercetin-3-methyl ether
7j92c373rh ,
unii-7j92c373rh
quercetin 3-o-methyl ether
flavone, 3',4',5,7-tetrahydroxy-3-methoxy-
HMS2271J03
AKOS015999072
FT-0672191
5,7,3',4'-tetrahydroxy-3-methoxyflavone
3-o-methyl quercetin
3-methylquercetol
3-methoxy-3',4',5,7-tetrahydroxyflavone
SCHEMBL380558
DTXSID20164032
3-o-methylquercetin, >=97% (hplc)
1195659-35-8
Q23068616
methylquercetin, 3-o-
quercetin 3-monomethyl ether
HY-N1860
CS-0017729
A884341
MS-24652
3,4,5,7-tetrahydroxy-3-methoxyflavone
PD150612
E87133
GLXC-16648
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
monomethoxyflavoneAny methoxyflavone with a single methoxy substituent.
tetrahydroxyflavoneAny hydroxyflavone carrying four hydroxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (50)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency16.07870.003245.467312,589.2998AID2517; AID2572
Chain A, HADH2 proteinHomo sapiens (human)Potency10.00000.025120.237639.8107AID886
Chain B, HADH2 proteinHomo sapiens (human)Potency10.00000.025120.237639.8107AID886
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency56.23410.631035.7641100.0000AID504339
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency17.03900.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency17.78280.125919.1169125.8920AID2549
endonuclease IVEscherichia coliPotency7.94330.707912.432431.6228AID2565
Nrf2Homo sapiens (human)Potency35.48130.09208.222223.1093AID624171
thioredoxin reductaseRattus norvegicus (Norway rat)Potency44.66840.100020.879379.4328AID588453
WRNHomo sapiens (human)Potency31.62280.168331.2583100.0000AID651768
ATAD5 protein, partialHomo sapiens (human)Potency22.13370.004110.890331.5287AID504466; AID504467
GLS proteinHomo sapiens (human)Potency35.48130.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency9.76130.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency18.25630.180013.557439.8107AID1460
thioredoxin glutathione reductaseSchistosoma mansoniPotency28.18380.100022.9075100.0000AID485364
Smad3Homo sapiens (human)Potency0.22390.00527.809829.0929AID588855
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency5.62340.707912.194339.8107AID720542
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency35.48130.707936.904389.1251AID504333
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency11.22020.016525.307841.3999AID602332
beta-2 adrenergic receptorHomo sapiens (human)Potency26.39560.00586.026332.6427AID492947; AID588463; AID588790
Bloom syndrome protein isoform 1Homo sapiens (human)Potency11.22020.540617.639296.1227AID2528
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency35.48130.036619.637650.1187AID2100
huntingtin isoform 2Homo sapiens (human)Potency3.54810.000618.41981,122.0200AID1688
DNA polymerase betaHomo sapiens (human)Potency4.46680.022421.010289.1251AID485314
flap endonuclease 1Homo sapiens (human)Potency25.11890.133725.412989.1251AID588795
DNA polymerase eta isoform 1Homo sapiens (human)Potency16.42330.100028.9256213.3130AID588591; AID720502
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency38.88270.050127.073689.1251AID588590; AID720496
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency12.58930.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency12.58930.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency12.58930.15855.287912.5893AID540303
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency8.11600.00798.23321,122.0200AID2546; AID2551
gemininHomo sapiens (human)Potency16.36010.004611.374133.4983AID624297
DNA polymerase kappa isoform 1Homo sapiens (human)Potency13.35730.031622.3146100.0000AID588579
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency39.81070.00419.962528.1838AID2675
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)Potency10.24350.058010.694926.6086AID602310; AID651813
DNA dC->dU-editing enzyme APOBEC-3F isoform aHomo sapiens (human)Potency13.28040.025911.239831.6228AID651814; AID651815
Rap guanine nucleotide exchange factor 3Homo sapiens (human)Potency31.62286.309660.2008112.2020AID720709
Glutamate receptor 1Rattus norvegicus (Norway rat)Potency10.00000.01418.602439.8107AID2572
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency10.00000.001551.739315,848.9004AID2572
Glutamate receptor 3Rattus norvegicus (Norway rat)Potency10.00000.01418.602439.8107AID2572
Glutamate receptor 4Rattus norvegicus (Norway rat)Potency10.00000.01418.602439.8107AID2572
phosphoglycerate kinaseTrypanosoma brucei brucei TREU927Potency25.11890.07578.474229.0628AID602233
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency11.99550.060110.745337.9330AID485367
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
integrase, partialHuman immunodeficiency virus 1IC50 (µMol)23.38800.07953.52039.9390AID1053171; AID1053172
lens epithelium-derived growth factor p75Homo sapiens (human)IC50 (µMol)23.38800.07953.52039.9390AID1053171; AID1053172
rac GTPase-activating protein 1 isoform aHomo sapiens (human)IC50 (µMol)30.34007.390057.8904301.2400AID624330
Xanthine dehydrogenase/oxidaseBos taurus (cattle)IC50 (µMol)31.60000.00303.10159.8000AID338975
Enoyl-acyl-carrier protein reductase Plasmodium falciparum (malaria parasite P. falciparum)IC50 (µMol)35.20000.06601.549910.0000AID611702
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glycogen synthase kinase-3 alphaHomo sapiens (human)AC501.92700.013529.7434171.7000AID463203
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (28)

Processvia Protein(s)Taxonomy
angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 3Homo sapiens (human)
signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 3Homo sapiens (human)
associative learningRap guanine nucleotide exchange factor 3Homo sapiens (human)
Rap protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of actin cytoskeleton organizationRap guanine nucleotide exchange factor 3Homo sapiens (human)
negative regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
intracellular signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of GTPase activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of protein export from nucleusRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of stress fiber assemblyRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
establishment of endothelial barrierRap guanine nucleotide exchange factor 3Homo sapiens (human)
cellular response to cAMPRap guanine nucleotide exchange factor 3Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 3Homo sapiens (human)
proteolysisInterstitial collagenaseHomo sapiens (human)
protein metabolic processInterstitial collagenaseHomo sapiens (human)
extracellular matrix disassemblyInterstitial collagenaseHomo sapiens (human)
collagen catabolic processInterstitial collagenaseHomo sapiens (human)
positive regulation of protein-containing complex assemblyInterstitial collagenaseHomo sapiens (human)
cellular response to UV-AInterstitial collagenaseHomo sapiens (human)
extracellular matrix organizationInterstitial collagenaseHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (18)

Processvia Protein(s)Taxonomy
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein domain specific bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
endopeptidase activityInterstitial collagenaseHomo sapiens (human)
metalloendopeptidase activityInterstitial collagenaseHomo sapiens (human)
serine-type endopeptidase activityInterstitial collagenaseHomo sapiens (human)
peptidase activityInterstitial collagenaseHomo sapiens (human)
zinc ion bindingInterstitial collagenaseHomo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
xanthine oxidase activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
iron ion bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
molybdenum ion bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
protein homodimerization activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
FAD bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
cortical actin cytoskeletonRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
microvillusRap guanine nucleotide exchange factor 3Homo sapiens (human)
endomembrane systemRap guanine nucleotide exchange factor 3Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
lamellipodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
filopodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular exosomeRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular regionInterstitial collagenaseHomo sapiens (human)
extracellular matrixInterstitial collagenaseHomo sapiens (human)
extracellular spaceInterstitial collagenaseHomo sapiens (human)
plasma membraneGlutamate receptor 1Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
extracellular spaceXanthine dehydrogenase/oxidaseBos taurus (cattle)
peroxisomeXanthine dehydrogenase/oxidaseBos taurus (cattle)
xanthine dehydrogenase complexXanthine dehydrogenase/oxidaseBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (148)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID353599Inhibition of CAMK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID355607Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 to 48 hrs at 37 degC by liquid dilution method
AID1188619Anticancer activity against human LOXIMVI cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID399298Inhibition of aldose reductase at 0.01 uM
AID360589Antiplatelet activity against washed rabbit platelet assessed as thrombin-induced platelet aggregation at 300 uM administered 3 mins before thrombin challenge1995Journal of natural products, Dec, Volume: 58, Issue:12
Novel antiplatelet naphthalene from Rhamnus nakaharai.
AID1873861Inhibition of actin (unknown origin) polymerization2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID666769Inhibition of thrombin in New Zealand rabbit plasma assessed as prothrombin time at 100 uM by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID1153995Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 25 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID596753Cytotoxicity against human HepG2(2.2.15) cells after 8 days by MTT assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Homoflavonoid glucosides from Ophioglossum pedunculosum and their anti-HBV activity.
AID1188616Anticancer activity against human 292G cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1234562Neuroprotective activity against middle cerebral artery occlusion-induced focal cerebral ischemia in Sprague-Dawley rat assessed as reduction in absolute infarct total volume at 10 mg/kg, iv administered 30 mins after MCA occlusion measured after 2 hrs of2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects.
AID1188609Anticancer activity against human H460 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1153998Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 50 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID1188613Anticancer activity against human NCI-H522 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1873856Binding affinity to HSP73 in mouse B16-F10 cell lysate by pull down assay2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID666770Inhibition of thrombin in New Zealand rabbit plasma assessed as activated partial thromboplastin time at 100 uM after 3 mins by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID235260Therapeutic Index measured as the ratio of CyD50(polio) / ED99(polio) values1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID611702Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry2011Journal of natural products, Jun-24, Volume: 74, Issue:6
Isoflavone dimers and other bioactive constituents from the figs of Ficus mucuso.
AID1154014Induction of melanogenesis-stimulating activity in mouse B16F0 cells assessed as increase in TRP-1 protein expression at 3.1 to 12.5 uM after 72 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID404008Cytotoxicity against human KB cells
AID611698Inhibition of Escherichia coli beta-glucuronidase assessed as inhibition of p-nitrophenyl-beta-D-glucuronide hydrolysis at 0.20 mM preincubated for 30 mins measured 30 mins after substrate addition by spectrophotometry2011Journal of natural products, Jun-24, Volume: 74, Issue:6
Isoflavone dimers and other bioactive constituents from the figs of Ficus mucuso.
AID355599Antibacterial activity against Escherichia coli ATCC 25922 after 24 to 48 hrs at 37 degC by liquid dilution method
AID353598Inhibition of CK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID1593609Antioxidant activity in pH 7.4 PBS assessed as H2O2 oxidation at 50 uM incubated for 10 mins in presence of HRP and H2O2 by UV spectroscopy and HPLC analysis relative to control2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID1323132Antioxidant activity assessed as DPPH free radical scavenging activity by measuring remaining DPPH at 5 uM after 15 to 60 mins relative to trolox2016Journal of natural products, 07-22, Volume: 79, Issue:7
Effects of Functional Groups and Sugar Composition of Quercetin Derivatives on Their Radical Scavenging Properties.
AID336915Antiviral activity against Measles virus infected in african green monkey Vero cells assessed as ratio of viral titer in absence to presence of compound at 500 ug/ml by 50% endpoint titration technique
AID162237Cytotoxic dose at which 50% growth of normal cells is inhibited1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID1873860Binding affinity to HSP73 in mouse B16-F10 cell lysate by Western blot analysis2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID1154016Induction of melanogenesis-stimulating activity in mouse B16F0 cells assessed as increase in p-p38 MAPK level at 3.1 to 12.5 uM after 72 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID1234559Aqueous solubility of the compound at room temperature by HPLC2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects.
AID1873848Binding affinity to human MMP-1 catalytic domain (100 to 269 residues) expressed in Escherichia coli BL21 Star (DE3) by SPR analysis2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID378510Antiviral activity against hepatitis B virus infected in human MS-G2 cells assessed as surface antigen secretion at 25 uM2005Journal of natural products, Mar, Volume: 68, Issue:3
Homoflavonoids from Ophioglossum petiolatum.
AID1873847Inhibition of MMP-1 (unknown origin) using FRET substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by fluorescence assay2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID355887Antimicrobial activity against Proteus mirabilis isolates after 36 hrs under aerobic condition by microdilution method2003Journal of natural products, May, Volume: 66, Issue:5
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
AID1873852Binding affinity to human 15N-labelled MMP-1 catalytic domain (100 to 269 residues) expressed in Escherichia coli BL21 Star (DE3) assessed as chemical shift perturbation at E99 residue at 500 uM by 1H-15N HSQC spectra analysis2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID355611Antifungal activity against Aspergillus flavus after 7 days at 27 degC by liquid dilution method
AID1593610Antioxidant activity in pH 7.4 PBS assessed as reactivity against GSH at 50 uM incubated for 10 mins in presence of HRP and H2O2 in presence of 40 uM GSH by HPLC-DAD and HPLC-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID1593613Neuroprotective activity in Sprague-Dawley rat CGN cells assessed as protection against H2O2-induced cytotoxicity by measuring increase in cell viability at 5 to 100 uM pre-incubated for 24 hrs before H2O2 stimulation for 24 hrs by MTT assay2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID1234556Antioxidant activity assessed as DPPH radical scavenging activity after 30 min2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects.
AID1234564Neuroprotective activity against middle cerebral artery occlusion-induced focal cerebral ischemia in Sprague-Dawley rat assessed as reduction in edema at 10 mg/kg, iv administered 30 mins after MCA occlusion measured after 2 hrs of reperfusion by TTC stai2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects.
AID1608396Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 18 hrs2019Bioorganic & medicinal chemistry, 09-01, Volume: 27, Issue:17
Natural product derived promising anti-MRSA drug leads: A review.
AID1188620Anticancer activity against human M14 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID162249Minimal dose which produces titer reduction at 10 ug/mL (mD RF10e3)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID1873850Binding affinity to human MMP-1 catalytic domain (100 to 269 residues) expressed in Escherichia coli BL21 Star (DE3) in absence of Ca2+ by SPR analysis2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID1154013Induction of melanogenesis-stimulating activity in mouse B16F0 cells assessed as increase in tyrosinase protein expression at 3.1 to 12.5 uM after 72 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID338975Inhibition of cow milk xanthine oxidase
AID1188608Anticancer activity against human NCI-H157 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1234561Neuroprotective activity against middle cerebral artery occlusion-induced focal cerebral ischemia in Sprague-Dawley rat assessed as reduction in absolute infarct volume in cortex at 10 mg/kg, iv administered 30 mins after MCA occlusion measured after 2 hr2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects.
AID355609Antibacterial activity against Staphylococcus aureus ATCC 12228 after 24 to 48 hrs at 37 degC by liquid dilution method
AID439062Antioxidant activity in rat liver homogenate assessed as inhibition of iron-ascorbic acid mix-induced lipid peroxidation by TBARS assay2009Bioorganic & medicinal chemistry letters, Nov-01, Volume: 19, Issue:21
Glucose-containing flavones--their synthesis and antioxidant and neuroprotective activities.
AID355615Antifungal activity against Paecilomyces after 7 days at 27 degC by liquid dilution method
AID293299Antioxidant activity in BALB/c mouse BM cells assessed as inhibition of ROS production2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID355605Antibacterial activity against Serratia marcescens ATCC 8100 after 24 to 48 hrs at 37 degC by liquid dilution method
AID1188610Anticancer activity against human NCI-H1792 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID360796Antiplatelet activity against washed rabbit platelet assessed as arachidonic acid-induced platelet aggregation at 300 uM administered 3 mins before arachidonic acid challenge1995Journal of natural products, Dec, Volume: 58, Issue:12
Novel antiplatelet naphthalene from Rhamnus nakaharai.
AID1323135Antioxidant activity assessed as DPPH free radical scavenging activity by measuring decrease in fluorescence intensity at 0.015 mmol measured after 30 mins in presence of methyl gallate by 13C-NMR spectroscopy2016Journal of natural products, 07-22, Volume: 79, Issue:7
Effects of Functional Groups and Sugar Composition of Quercetin Derivatives on Their Radical Scavenging Properties.
AID1873854Binding affinity to MMP-1 in mouse B16-F10 cell lysate by pull down assay2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID355604Antibacterial activity against Salmonella Typhimurium ATCC 14028 after 24 to 48 hrs at 37 degC by liquid dilution method
AID355606Antibacterial activity against Shigella dysenteriae after 24 to 48 hrs at 37 degC by liquid dilution method
AID439061Antioxidant activity assessed as inhibition of xanthine/xanthine oxidase system-induced superoxide anion radical scavenging activity after 20 mins2009Bioorganic & medicinal chemistry letters, Nov-01, Volume: 19, Issue:21
Glucose-containing flavones--their synthesis and antioxidant and neuroprotective activities.
AID1188607Anticancer activity against human A549 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID353591Enhancement of HSP27 Ser78 phosphorylation in human HeLa cells at 50 ug/mL treated for 1 hr2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID336913Antiviral activity against Coxsackievirus infected in african green monkey Vero cells assessed as ratio of viral titer in absence to presence of compound at 5 ug/ml by 50% endpoint titration technique
AID1188622Anticancer activity against human HeLa cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID293298Antioxidant activity assessed as inhibition of superoxide production by xanthine/xanthine oxidase method2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID611697Inhibition of Escherichia coli beta-glucuronidase assessed as inhibition of p-nitrophenyl-beta-D-glucuronide hydrolysis preincubated for 30 mins measured 30 mins after substrate addition by spectrophotometry2011Journal of natural products, Jun-24, Volume: 74, Issue:6
Isoflavone dimers and other bioactive constituents from the figs of Ficus mucuso.
AID355602Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 to 48 hrs at 37 degC by liquid dilution method
AID1154002Cytotoxicity against mouse B16F0 cells assessed as cell viability at 50 uM after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID314064Inhibition of LPS-induced NO production in mouse BV2 cells2008Bioorganic & medicinal chemistry letters, Feb-15, Volume: 18, Issue:4
In vitro anti-inflammatory activity of 3-O-methyl-flavones isolated from Siegesbeckia glabrescens.
AID1234560Neuroprotective activity against middle cerebral artery occlusion-induced focal cerebral ischemia in Sprague-Dawley rat assessed as reduction in absolute infarct volume in striatum at 10 mg/kg, iv administered 30 mins after MCA occlusion measured after 2 2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects.
AID1188612Anticancer activity against human H266 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID355614Antifungal activity against Microsporum canis after 7 days at 27 degC by liquid dilution method
AID293297Antioxidant activity assessed as DPPH radical scavenging activity after 20 min2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID1154015Induction of melanogenesis-stimulating activity in mouse B16F0 cells assessed as increase in MITF protein expression at 3.1 to 12.5 uM after 72 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID355610Antibacterial activity against Streptococcus pyogenes ATCC 19651 after 24 to 48 hrs at 37 degC by liquid dilution method
AID439060Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2009Bioorganic & medicinal chemistry letters, Nov-01, Volume: 19, Issue:21
Glucose-containing flavones--their synthesis and antioxidant and neuroprotective activities.
AID355885Antimicrobial activity against Helicobacter pylori isolates after 36 hrs under aerobic condition by microdilution method2003Journal of natural products, May, Volume: 66, Issue:5
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
AID314066Peroxynitrite scavenging activity assessed as inhibition of DHR 123 oxidation2008Bioorganic & medicinal chemistry letters, Feb-15, Volume: 18, Issue:4
In vitro anti-inflammatory activity of 3-O-methyl-flavones isolated from Siegesbeckia glabrescens.
AID353590Inhibition of heat-induced HSP70 expression in human Jurkat cells at 50 ug/mL treated for 1 hr before heat induction by Western blot2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID596755Antiviral activity against HBV transfected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion at nontoxic concentration by ELISA2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Homoflavonoid glucosides from Ophioglossum pedunculosum and their anti-HBV activity.
AID1188618Anticancer activity against human M4E cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID336914Antiviral activity against Herpes simplex virus type 1 infected in african green monkey Vero cells assessed as ratio of viral titer in absence to presence of compound at 500 ug/ml by 50% endpoint titration technique
AID1873857Binding affinity to MLK3 in mouse B16-F10 cell lysate by pull down assay2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID1154004Cytotoxicity against mouse B16F0 cells assessed as cell viability at 12.5 uM after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID1873855Binding affinity to beta-actin in mouse B16-F10 cell lysate by pull down assay2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID355888Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 36 hrs under aerobic condition by microdilution method2003Journal of natural products, May, Volume: 66, Issue:5
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
AID399301Inhibition of aldose reductase at 10 uM
AID1153999Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 25 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID1239713Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation at 100 uM pre-incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Potential therapeutic agents for circulatory diseases from Bauhinia glauca Benth.subsp. pernervosa. (Da Ye Guan Men).
AID1234557Antioxidant activity assessed as superoxide anion radical scavenging activity after 20 mins by xanthine/xanthine oxidase method2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects.
AID1873851Binding affinity to human 15N-labelled MMP-1 catalytic domain (100 to 269 residues) expressed in Escherichia coli BL21 Star (DE3) assessed as chemical shift perturbation at F97 residue at 500 uM by 1H-15N HSQC spectra analysis2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID399299Inhibition of aldose reductase at 0.1 uM
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID162238Minimum drug concentration at which 99% of the polio virus is inhibited1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID1188615Anticancer activity against human H1299 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1323133Antioxidant activity assessed as DPPH free radical scavenging activity at 5 uM after 15 to 60 mins in presence of CuSO4.5H2O2016Journal of natural products, 07-22, Volume: 79, Issue:7
Effects of Functional Groups and Sugar Composition of Quercetin Derivatives on Their Radical Scavenging Properties.
AID355886Antimicrobial activity against Escherichia coli ATCC 35218 after 36 hrs under aerobic condition by microdilution method2003Journal of natural products, May, Volume: 66, Issue:5
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
AID1188617Anticancer activity against human Calu1 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID360802Antiplatelet activity against washed rabbit platelet assessed as PAF-induced platelet aggregation at 300 uM administered 3 mins before PAF challenge1995Journal of natural products, Dec, Volume: 58, Issue:12
Novel antiplatelet naphthalene from Rhamnus nakaharai.
AID1188611Anticancer activity against human NCI-H1944 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1873859Binding affinity to beta-actin in mouse B16-F10 cell lysate by Western blot analysis2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID1873849Binding affinity to human MMP-1 catalytic domain (100 to 269 residues) expressed in Escherichia coli BL21 Star (DE3) in absence of Zn2+ by SPR analysis2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID355601Antibacterial activity against Proteus vulgaris ATCC 27853 after 24 to 48 hrs at 37 degC by liquid dilution method
AID336917Antiviral activity against Poliovirus infected in african green monkey Vero cells assessed as ratio of viral titer in absence to presence of compound at 5 ug/ml by 50% endpoint titration technique
AID360799Antiplatelet activity against washed rabbit platelet assessed as collagen-induced platelet aggregation at 300 uM administered 3 mins before collagen challenge1995Journal of natural products, Dec, Volume: 58, Issue:12
Novel antiplatelet naphthalene from Rhamnus nakaharai.
AID1607883Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess reagent based assay2019European journal of medicinal chemistry, Oct-01, Volume: 179Human disorders associated with inflammation and the evolving role of natural products to overcome.
AID1188621Anticancer activity against human SKBR cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID355608Antibacterial activity against Mycobacterium smegmatis ATCC 607 after 24 to 48 hrs at 37 degC by liquid dilution method
AID355603Antibacterial activity against Pseudomonas solanacearum after 24 to 48 hrs at 37 degC by liquid dilution method
AID355600Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 24 to 48 hrs at 37 degC by liquid dilution method
AID1153994Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 50 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID162244The ratio of the poliovirus viral titer of the virus control (reduction factor) to the viral titer in the presence of the maximal non-toxic dose (RF MNTD)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID1873858Binding affinity to MMP-1 in mouse B16-F10 cell lysate by Western blot analysis2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID1188614Anticancer activity against human HOP62 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID355613Antifungal activity against Epidermophyton floccosum after 7 days at 27 degC by liquid dilution method
AID1593607Antioxidant activity in pH 7.4 PBS assessed as ABTS+ radical scavenger activity incubated under absence of light for 16 hrs2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID379054Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA1999Journal of natural products, Mar, Volume: 62, Issue:3
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
AID355612Antifungal activity against Candida albicans CBS 562 after 24 to 48 hrs at 37 degC by liquid dilution method
AID611778Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate at 0.1 mM peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry2011Journal of natural products, Jun-24, Volume: 74, Issue:6
Isoflavone dimers and other bioactive constituents from the figs of Ficus mucuso.
AID399300Inhibition of aldose reductase at 1 uM
AID336918Antiviral activity against Semliki forest virus infected in african green monkey Vero cells assessed as ratio of viral titer in absence to presence of compound at 500 ug/ml by 50% endpoint titration technique
AID314065Decrease in iNOS protein expression in LPS-activated mouse BV2 cells at 20 uM2008Bioorganic & medicinal chemistry letters, Feb-15, Volume: 18, Issue:4
In vitro anti-inflammatory activity of 3-O-methyl-flavones isolated from Siegesbeckia glabrescens.
AID439063Neuroprotective activity against H2O2-induced neuronal damage in Sprague-Dawley rat cerebral cortical cells after 20 to 24 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Nov-01, Volume: 19, Issue:21
Glucose-containing flavones--their synthesis and antioxidant and neuroprotective activities.
AID1234563Neuroprotective activity against middle cerebral artery occlusion-induced focal cerebral ischemia in Sprague-Dawley rat assessed as reduction in corrected total infarct volume at 10 mg/kg, iv administered 30 mins after MCA occlusion measured after 2 hrs o2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects.
AID1154000Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 12.5 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID1153996Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 12.5 uM after 72 hrs by spectrophotometry relative to control2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID1154026Induction of melanogenesis-stimulating activity in mouse B16F0 cells assessed as increase in TRP-2 protein expression at 3.1 to 12.5 uM after 72 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID162242Maximal non-toxic dose (MNTD) that shows antiviral activity.1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID666771Inhibition of thrombin in New Zealand rabbit plasma assessed as fibrinogen level at 100 uM by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID1593608Antioxidant activity in Sprague-Dawley rat brain homogenates assessed as inhibition of lipoperoxidation incubated for 40 mins by fluorescence based assay2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID379055Cytotoxicity against human monocytes assessed as depletion of cellular LDH activity1999Journal of natural products, Mar, Volume: 62, Issue:3
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
AID1154003Cytotoxicity against mouse B16F0 cells assessed as cell viability at 25 uM after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK.
AID666768Inhibition of thrombin in New Zealand rabbit plasma assessed as thrombin time at 100 uM after 3 mins by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID1234558Antioxidant activity in rat liver microsomes assessed as reduction in iron-ascorbic acid-induced lipid peroxidase activity after 30 mins by TBARS assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects.
AID355598Antibacterial activity against Enterobacter cloacae ATCC 23355 after 24 to 48 hrs at 37 degC by liquid dilution method
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (7.14)18.2507
2000's12 (28.57)29.6817
2010's25 (59.52)24.3611
2020's2 (4.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.23 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (95.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]